Cardiac conduction system LGMD INPP5K Myotubes LMNA-related congenital muscular dystrophy A-type lamins CRISPR AAV VECTOR LMNA gene RNA interference Titin C elegans Laminopathie Becker muscular dystrophy Actionability Butyrylcholinesterase Dystrophie musculaire BiP Biomarker Myopathy Angiotensin-converting enzyme inhibitor Rare diseases COVID-19 Allele‐specific silencing therapy Lamins Adult SMA Ehlers‐Danlos Syndrome Maladies rares et orphelines Laminopathies Duchenne muscular dystrophy Exome Hypermobile EDS Connective tissue A-type lamin Joint laxity Emerin Cardiology Rare neuromuscular diseases Calcium handling Gene therapy Myogenesis CSF protein Centronuclear myopathy Muscle MRI C2C12 IPSC Nuclear envelope Actionable gene CMTX Acetyltransferase Errance diagnostique Lamin A/C Dystrophine Maladies rares Allele-specific silencing therapy Treatment delay Base de données FAIR Heart Muscle biopsy Cancer biomarkers Dilated cardiomyopathy BVES Cardiomyopathy Muscular dystrophy MD Cancer Muscular dystrophy Congenital muscular dystrophy Diagnosis Laminopathy Mouse Next generation sequencing Clinical trial Regeneration AAV Muscle Alternative splicing Autophagosome maturation Lamin A/C nuclei Heart failure Mutations Treatment COL1A1 POPDC1 Patient registry Emery-Dreifuss muscular dystrophy Therapy COL6A1 Skeletal muscle Lamin A/C LMNA gene Neuromuscular diseases Biological sciences Dynamin 2 Allele-specific silencing Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS GNE Angiotensin-converting enzyme inhibitors COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Myopathies Myologie LMNA